申请人:DYCK Brian
公开号:US20110166116A1
公开(公告)日:2011-07-07
New compounds are disclosed which have utility in the treatment of a variety of metabolic related conditions in a patient. The compounds of this invention have the structure (I):
wherein R
1
, R
2
, R
3
, n, p, q, and Ar are as defined herein, including stereoisomers, and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising a compound of this invention, as well as methods relating to the use thereof in a patient in need thereof.
本发明披露了一种新化合物,其在治疗患者的各种代谢相关疾病方面具有用途。本发明的化合物具有结构(I):其中R1、R2、R3、n、p、q和Ar的定义如本文所述,包括立体异构体和药物可接受的盐。本发明还披露了包括本发明化合物的制药组合物,以及与在需要时使用该化合物的相关方法。